| Target Price | HK$76.50 |
| Price | HK$58.50 |
| Potential |
30.77%
register free of charge
|
| Number of Estimates | 18 |
|
18 Analysts have issued a price target JD Health International 2026 .
The average JD Health International target price is HK$76.50.
This is
30.77%
register free of charge
HK$101.17
72.94%
register free of charge
HK$45.85
21.62%
register free of charge
|
|
| A rating was issued by 25 analysts: 22 Analysts recommend JD Health International to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the JD Health International stock has an average upside potential 2026 of
30.77%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 64.39 | 80.47 |
| 8.65% | 24.97% | |
| EBITDA Margin | 5.95% | 5.87% |
| 183.90% | 1.34% | |
| Net Margin | 7.16% | 8.50% |
| 78.84% | 18.78% |
21 Analysts have issued a sales forecast JD Health International 2025 . The average JD Health International sales estimate is
This results in the following potential growth metrics:
22 JD Health International Analysts have issued a net profit forecast 2025. The average JD Health International net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 1.46 | 2.14 |
| 94.67% | 46.58% | |
| P/E | 27.36 | |
| EV/Sales | 1.65 |
22 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International EPS is
This results in the following potential growth metrics and future valuations:
JD Health International...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


